Home Cart Sign in  
Chemical Structure| 486-56-6 Chemical Structure| 486-56-6

Structure of Cotinine
CAS No.: 486-56-6

Chemical Structure| 486-56-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cotinine is an alkaloid found in tobacco and is also the predominant metabolite of nicotine, used as a biomarker for exposure to tobacco smoke.

Synonyms: (S)-Cotinine; NIH-10498; NIH 10498, NIH10498, NIH-10498, (-)-Cotinine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cotinine

CAS No. :486-56-6
Formula : C10H12N2O
M.W : 176.22
SMILES Code : O=C1N(C)[C@H](C2=CC=CN=C2)CC1
Synonyms :
(S)-Cotinine; NIH-10498; NIH 10498, NIH10498, NIH-10498, (-)-Cotinine
MDL No. :MFCD00077696
InChI Key :UIKROCXWUNQSPJ-VIFPVBQESA-N
Pubchem ID :854019

Safety of Cotinine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P301+P312+P330-P304+P340+P312-P305+P351+P338-P337+P313

Isoform Comparison

Biological Activity

Description
Cotinine, a (-)-enantiomer and a significant metabolite of nicotine found in tobacco, is used as a biomarker to assess tobacco smoke exposure[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
HCC1419 cells 0.02–2000 nM 72 h To evaluate the effect of ERC6 and cotinine-duocarmycin complex on the viability of HCC1419 cells. The results showed that the complex exhibited lower antitumor activity against HCC1419 cells with an IC50 value of 100 nM. Exp Mol Med. 2018 May 24;50(5):1-14
MCF7 cells 0.02–2000 nM 72 h To evaluate the effect of ERC6 and cotinine-duocarmycin complex on the viability of MCF7 cells. The results showed that the complex exhibited lower antitumor activity against MCF7 cells with an IC50 value of 40 nM. Exp Mol Med. 2018 May 24;50(5):1-14
U87MG cells 0.02–2000 nM 72 h To evaluate the effect of ERC6 and cotinine-duocarmycin complex on the viability of U87MG cells. The results showed that the complex exhibited significant antitumor activity against U87MG cells with an IC50 value of 4.0 nM. Exp Mol Med. 2018 May 24;50(5):1-14
A549 cells 0.02–2000 nM 72 h To evaluate the effect of ERC6 and cotinine-duocarmycin complex on the viability of A549 cells. The results showed that the complex exhibited significant antitumor activity against A549 cells with an IC50 value of 0.3 nM. Exp Mol Med. 2018 May 24;50(5):1-14
BV-2 microglial cells 0.5-1.6 mM 24 h Cotinine inhibited LPS-induced NO and TNF-α production and blocked microglial activation Innovation (Camb). 2021 Apr 30;2(2):100111

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 male mice Fear conditioning and extinction model Continuous infusion into the medial prefrontal cortex 5 mg/ml Continuous for 2 weeks, starting 1 week before fear conditioning Cotinine enhanced fear extinction and prevented astrocyte loss by mechanisms involving the a7 and a4b2 nAChRs, and modulated BMP2 and BMP8 expression in the mPFC Front Pharmacol. 2020 Apr 2;11:303
SD rats Deep vein thrombosis model Gavage 10 μg/kg Once daily for 2 weeks Cotinine aggravates deep vein thrombosis and inflammation in rats by activating the TLR-4/NF-κB signaling pathway. Biosci Rep. 2020 Jun 26;40(6):BSR20201293

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.67mL

1.13mL

0.57mL

28.37mL

5.67mL

2.84mL

56.75mL

11.35mL

5.67mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories